Elvira Di Nardo

Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma.

V. Pavone, A. Ostuni, G. Milone, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score

G. Gaidano, F. Merli, F. Lanza, 2018, Bone Marrow Transplantation.